Brief: Paion presents positive remimazolam phase III colonoscopy results
19/10/2016 06:30
Oct 19 (Reuters) - Paion AG PA8G.DE :
* Positive remimazolam phase III colonoscopy results
presented at 2016 American college of gastroenterology annual
scientific meeting
Source text for Eikon: ID:nEQQJwLS
Further company coverage: PA8G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on PAION AG
See all newsBrief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
Brief: Paion AG Reports Developments On Commercial Activities In Europe
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022